A phase II study of Carboplatin plus Pemetrexed plus Atezolizumab plus Bevacizumab in chemotherapyand immunotherapy-na??ve patients with stage IV non-squamous non-small cell lung cancer: Big TenCancer Research Consortium BTCRC-LUN17-139

Project: Research project

Project Details

Description

A phase II study of Carboplatin plus Pemetrexed plus Atezolizumab plus Bevacizumab in chemotherapy and immunotherapy-na??ve patients with stage IV non-squamous non-small cell lung cancer: Big Ten Cancer Research Consortium BTCRC-LUN17-139
StatusFinished
Effective start/end date3/18/19 → 3/30/24

Funding

  • BIG TEN CANCER RESEARCH CONSORTIUM
  • GENENTECH, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint